Mechanism of the dual action self-potentiating antitubercular drug morphazinamide. [PDF]
Ostrer L +8 more
europepmc +1 more source
The epidemiology and gene mutation characteristics of pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates in Southern China. [PDF]
Wang N +17 more
europepmc +1 more source
Determining the minimum inhibitory concentrations of pyrazinamide against <i>Mycobacterium tuberculosis</i> clinical isolates at a neutral pH of 6.8 using the broth microdilution method. [PDF]
Tamblin M, Shi W, Chen L, Reynolds J.
europepmc +1 more source
Characterization of pulmonary tuberculosis in high-altitude region using nanopore targeted sequencing. [PDF]
Xia A +11 more
europepmc +1 more source
<i>In silico</i> analysis of the functional implications of drug resistance associated mutations in <i>Mycobacterium tuberculosis</i>. [PDF]
Pal A +4 more
europepmc +1 more source
Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020. [PDF]
Tamilzhalagan S +16 more
europepmc +1 more source
Exploring transmission dynamics in epidemiologically linked pulmonary tuberculosis cases and household contacts: a WGS-based investigation. [PDF]
Seid G +12 more
europepmc +1 more source
Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network
Dissanayake D +4 more
europepmc +1 more source

